| Financial Year |
March 31 2023 |
| Monetary Funds |
1,643,280,812.89 |
| Held-for-trading Financial Assets |
676,430,200.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
180,546,346.93 |
| Advances to Suppliers |
333,652,017.16 |
| Other Receivables |
42,285,131.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
639,382,867.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
345,520,969.68 |
| Total Current Assets |
3,862,650,559.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
54,465,282.34 |
| Fixed Assetes |
204,270,480.25 |
| Under-construction Projects |
88,496,627.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
93,995,738.16 |
| R&D expenses |
33,114,008.66 |
| Goodwill |
57,653,962.10 |
| Long-Term Deferred and Prepaid Expenses |
44,229.98 |
| Deferred Income Tax Assets |
1,784,170.19 |
| Other Non-Current Assets |
82,233,600.38 |
| Sub-Total of Non-Current Assets |
2,768,168,623.03 |
| Total Assets |
6,630,819,182.59 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
660,177,625.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,288,609.56 |
| Taxes Payable |
11,117,116.91 |
| Interest Payable |
-- |
| Dividend Payable |
114,288.45 |
| Other payables |
95,702,767.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,389,695.93 |
| Other Current Liabilities |
19,205,239.70 |
| Sub-Total of Current Liabilities |
1,557,062,525.31 |
| Long-term Loans |
668,630.21 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
93,078,634.56 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,043,880.59 |
| Other Non-Current Liabilities |
5,139,844.59 |
| Sub-Total of Non-Current Liabilities |
145,443,321.30 |
| Total Liabilities |
1,702,505,846.61 |
| Paid-In Capital(Or Share Stock) |
790,500,000.00 |
| Capital Surplus |
783,805,592.79 |
| Surplus Reserve |
341,650,155.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,903,597,453.34 |
| Minority Stockholder's Interest |
54,072,767.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,874,240,568.70 |
| Owner's Equity（Stockholder's Equity） |
4,928,313,335.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,630,819,182.59 |
